METROPOLITAN LIFE INSURANCE CO/NY - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 95 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$17,118
-85.7%
1,979
-76.4%
0.00%
-50.0%
Q4 2021$119,752
-35.0%
8,3860.0%0.00%
-33.3%
Q3 2021$184,324
+64.3%
8,3860.0%0.00%
+50.0%
Q2 2021$112,2058,3860.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
BML Capital Management, LLC 781,292$2,039,1721.87%
GSA CAPITAL PARTNERS LLP 88,923$2320.02%
Glass Jacobson Investment Advisors llc 12,255$31,9860.02%
Rathbones Group PLC 289,803$756,3860.01%
N.E.W. Advisory Services LLC 12,960$33,8260.01%
Virtu Financial LLC 17,388$450.00%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$14,6870.00%
ALGERT GLOBAL LLC 14,680$380.00%
Close Asset Management Ltd 11,400$300.00%
Altshuler Shaham Ltd 12,847$33,4080.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders